Insight Molecular Diagnostics Inc.
IMDX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 25.1% | 56.9% | -56.4% | – |
| Gross Profit | $0 | $0 | -$0 | $0 |
| % Margin | 39.3% | 27.5% | -1.9% | 64.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,137.4% | -1,538.5% | -1,389.2% | -2,204.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,225% | -1,848.4% | -7,609.8% | -2,916.2% |
| EPS Diluted | -4.661 | -3.75 | -20 | -14.4 |
| % Growth | -24.3% | 81.3% | -38.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |